Bone marrow biopsy superiority over PET/CT in predicting progression‐free survival in a homogeneously‐treated cohort of diffuse large B‐cell lymphoma

Several studies have reported uneven results when evaluating the prognostic value of bone marrow biopsy (BMB) and PET/CT as part of the staging of diffuse large B‐cell lymphoma (DLBCL). The heterogeneity of the inclusion criteria and not taking into account selection and collinearity biases in the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen‐Liang, Tzu‐Hua, Martín‐Santos, Taida, Jerez, Andrés, Rodríguez‐García, Guillermo, Senent, Leonor, Martínez‐Millán, Cristina, Muiña, Begoña, Orero, Mayte, Teruel, Anabel, Martín, Alejandro, Gómez‐Espuch, Joaquín, Kennedy, Kyra, Benet, Carmen, Raya, José María, Fernández‐González, Marta, de la Cruz, Fátima, Guinot, Marta, Villegas, Carolina, Ballester, Isabel, Baile, Mónica, Moya, María, López‐Jiménez, Javier, Frutos, Laura, Navarro, José Luis, Uña, Jon, Fernández‐López, Rosa, Igua, Carolina, Contreras, José, Sánchez‐Vañó, Raquel, Cozar, María del Puig, Tamayo, Pilar, Mucientes, Jorge, Sánchez‐Blanco, José Javier, Pérez‐Ceballos, Elena, Ortuño, Francisco José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673915/
https://www.ncbi.nlm.nih.gov/pubmed/28960797
http://dx.doi.org/10.1002/cam4.1205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673915/
https://www.ncbi.nlm.nih.gov/pubmed/28960797
http://dx.doi.org/10.1002/cam4.1205

Ejemplares similares